Universitätsklinikum Freiburg

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients (2014) Fasching P, Jud S, Hauschild M, Kuemmel S, Schuette M, Warm M, Hanf V, et al. Journal article Mutations in WDR19 encoding the intraflagellar transport component IFT144 cause a broad spectrum of ciliopathies (2014) Fehrenbach H, Decker C, Eisenberger T, Frank V, Hampel T, Walden U, Amann KU, et al. Journal article Support vector machine-based prediction of local tumor control after stereotactic body radiation therapy for early-stage non-small cell lung cancer (2014) Klement RJ, Allgaeuer M, Appold S, Dieckmann K, Ernst I, Ganswindt U, Holy R, et al. Journal article Bone- and cartilage-protective effects of a monoclonal antibody against colony-stimulating factor 1 receptor in experimental arthritis (2014) Toh ML, Bonnefoy JY, Accart N, Cochin S, Pohle S, Haegel H, De Meyer M, et al. Journal article Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis (2014) Moinzadeh P, Aberer E, Ahmadi-Simab K, Blank N, Distler J, Fierlbeck G, Genth E, et al. Journal article Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply aggressive behaviour (2014) Schaefer IM, Stroebel P, Cameron S, Beham A, Otto C, Schildhaus HU, Agaimy A Journal article Introduction: B cell-mediated autoimmune diseases (2014) Winkler T, Voll RE Journal article, Editorial Treatment algorithm for metastatic renal cell carcinoma--recommendations based on evidence and clinical practice (2014) Bergmann L, Beck J, Bothe K, Brinkmann OA, Buse S, Goebell P, Gruenwald V, et al. Journal article Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels (2014) Sassi A, Lazaroski S, Wu G, Haslam SM, Fliegauf M, Mellouli F, Patiroglu T, et al. Journal article Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer (2014) Kunath F, Grobe HR, Ruecker G, Motschall E, Antes G, Dahm P, Wullich B, Meerpohl JJ Journal article